⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CUE News
Cue Biopharma, Inc.
Form 8-K
sec.gov
CUE
Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution
globenewswire.com
CUE
Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference
globenewswire.com
CUE
Form 8-K
sec.gov
CUE
Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments
globenewswire.com
CUE
Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
CUE
Form 8-K
sec.gov
CUE
Cue Biopharma Announces $30 Million Private Placement
globenewswire.com
CUE
Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody
globenewswire.com
CUE
Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company
globenewswire.com
CUE